Stevens Timothy P, Chess Patricia R, McConnochie Kenneth M, Sinkin Robert A, Guillet Ronnie, Maniscalco William M, Fisher Susan G
Division of Neonatology, Department of Pediatrics, Strong Children's Research Center, Golisano Children's Hospital at Strong, Rochester, New York 14642, USA.
Pediatrics. 2002 Sep;110(3):590-6. doi: 10.1542/peds.110.3.590.
Congenital diaphragmatic hernia (CDH) is a malformation of the diaphragm that allows bowel to enter the thoracic cavity, resulting in pulmonary hypoplasia and pulmonary hypertension. Approximately 50% of CDH patients are treated with extracorporeal membrane oxygenation (ECMO). The optimal gestational age for delivery of term infants with CDH at high risk for requiring ECMO is not known. The goal of this study was to compare survival of infants with CDH receiving ECMO born early term (38 0/7-39 6/7 weeks' gestation) with those born late term (40 0/7-41 6/7 weeks' gestation). Changes in survival rates of term infants and the factors associated with these changes were assessed over the 25 years that ECMO has been available.
Retrospective cohort study of infants with CDH treated with ECMO.
The Extracorporeal Life Support Organization registry of patients treated at active Extracorporeal Life Support Organization centers from April 1976 through June 2001.
Survival and clinical predictors of survival were compared between infants born early term (38 0/7-39 6/7 weeks' gestation) and infants born late term (40 0/7-41 6/7 weeks' gestation). Changes in survival rates over time and factors associated with survival were evaluated.
Among full-term infants with CDH treated with ECMO, late-term compared with early-term delivery was associated with improved survival (63% vs 53%). Among full-term survivors of ECMO, late-term infants spent less time on ECMO (181 vs 197 hours) and less time in the hospital (60 vs 67 days). In multivariate analysis, greater birth weight, higher 5-minute Apgar score, higher arterial pH and PCO(2) <50 torr before ECMO, and absence of a prenatal diagnosis of CDH were associated with survival. Since the late 1980s, survival of infants with CDH requiring ECMO decreased from 63% to 52%. The decreased survival rate was associated with increased rates of prenatal diagnosis, early-term delivery, lower birth weight, longer ECMO runs, and more frequent complications on ECMO.
Among term infants with CDH receiving ECMO, late-term delivery compared with early-term delivery is associated with improved survival, shorter ECMO duration, shorter hospital length of stay, and fewer complications on ECMO. These data suggest that, at least for the approximately 50% of CDH patients treated with ECMO, outcomes for infants with CDH may be improved by delay of elective delivery until 40 completed weeks of gestation.
先天性膈疝(CDH)是一种膈肌畸形,可使肠道进入胸腔,导致肺发育不全和肺动脉高压。约50%的CDH患者接受体外膜肺氧合(ECMO)治疗。对于有ECMO治疗高风险的足月CDH婴儿,最佳分娩孕周尚不清楚。本研究的目的是比较接受ECMO治疗的早产(38⁰/₇ - 39⁶/₇周妊娠)和足月产(40⁰/₇ - 41⁶/₇周妊娠)CDH婴儿的存活率。在ECMO应用的25年中,评估了足月婴儿存活率的变化以及与这些变化相关的因素。
对接受ECMO治疗的CDH婴儿进行回顾性队列研究。
1976年4月至2001年6月期间在体外生命支持组织(ELSO)活跃中心接受治疗的患者的ELSO登记册。
比较早产(38⁰/₇ - 39⁶/₇周妊娠)和足月产(40⁰/₇ - 41⁶/₇周妊娠)婴儿的存活率及生存的临床预测因素。评估存活率随时间的变化以及与生存相关的因素。
在接受ECMO治疗的足月CDH婴儿中,足月产与早产相比,存活率更高(63%对53%)。在ECMO的足月存活者中,足月产婴儿接受ECMO的时间更短(181小时对197小时),住院时间更短(60天对67天)。多因素分析显示,出生体重较大、5分钟阿氏评分较高、ECMO前动脉血pH值较高且PCO₂<50托以及未产前诊断出CDH与生存相关。自20世纪80年代末以来,需要ECMO治疗的CDH婴儿的存活率从63%降至52%。存活率下降与产前诊断率增加、早产、出生体重降低、ECMO运行时间延长以及ECMO并发症更频繁有关。
在接受ECMO治疗的足月CDH婴儿中,足月产与早产相比,存活率更高,ECMO持续时间更短,住院时间更短,ECMO并发症更少。这些数据表明,至少对于约50%接受ECMO治疗的CDH患者,将择期分娩推迟至妊娠40足周可能会改善CDH婴儿的预后。